No Data
No Data
Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $280
Evercore ISI Keeps Their Buy Rating on Alnylam Pharma (ALNY)
BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300
H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $500
Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.